Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
(OTCQB:CYTOF),(OTC US:CYTOF), Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) — Exploring use of Altamira's RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option to negotiate licensing and supply agreement Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond […]